Coronavirus Disease 2019 and Bone Marrow Transplantation: A Mini-review
Since the first incidence of coronavirus disease 2019 (COVID-19) was identified in 2019, the illness has rapidly spread, increasing the number of cases, hospital admissions, and fatalities associated with COVID-19. The epidemic is putting an unprecedented amount of stress on the health-care system,...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Wolters Kluwer Medknow Publications,
2024-05-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Since the first incidence of coronavirus disease 2019 (COVID-19) was identified in 2019, the illness has rapidly spread, increasing the number of cases, hospital admissions, and fatalities associated with COVID-19. The epidemic is putting an unprecedented amount of stress on the health-care system, including programs that perform both allogeneic and autologous hematopoietic stem cell transplantation (HSCT) and cellular treatment employing T cells. The risk of a severe COVID-19 infection in HSCT patients is widely acknowledged, and the COVID-19 vaccine is strongly advised. This mini-review provides a succinct overview of recent advances in COVID-19 and bone marrow transplantation. |
|---|---|
| Item Description: | 2070-1128 2227-4081 10.4103/mj.mj_40_23 |